| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Epidemiology and Prevention |
1 Cancer Risk Factor Branch and 2 Molecular and Nutritional Epidemiology Unit, CSPO-Scientific Institute of Tuscany Region, Florence, Italy; 3 Department of Environmental and Occupational Health, Utrecht University; 4 Julius Center for Health Sciences and Primary Care, University Medical Center, Utrecht, the Netherlands; 5 WHO, European Centre for Environment and Health, Bonn, Germany; 6 ISI Foundation; 7 University of Turin, Turin, Italy; 8 Istituto Mario Negri; 9 Genetics Research Institute; 10 Department of Epidemiology, National Cancer Institute, Milan, Italy; 11 Department of Environmental and Occupational Medicine, Aarhus, Denmark; 12 Department of Oncology, University of Cambridge; 13 Medical Research Council Dunn Human Nutrition Unit, Cambridge, United Kingdom; 14 IARC, Lyon, France; 15 Department of Clinical Epidemiology, Aalborg Hospital, Aarhus University Hospital, Aalborg, Denmark; 16 Institute of Cancer Epidemiology, Danish Cancer Society, Copenhagen, Denmark; 17 Institut National de la Sante et de la Recherche Medicale U521, Institut Gustave Roussy, Villejuif, France; 18 Division of Clinical Epidemiology, Deutsches Krebsforschungszentrum, Heidelberg, Germany; 19 German Institute of Human Nutrition, Potsdam-Rehbücke, Germany; 20 Department of Hygiene and Epidemiology, Medical School, University of Athens, Athens, Greece; 21 Cancer Registry, Azienda Ospedaliera "Civile MP Arezzo," Ragusa, Italy; 22 Dipartimento di Medicina Clinica e Sperimentale, Università Federico II, Naples, Italy; 23 Centre for Nutrition and Health, National Institute for Public Health and the Environment, Bilthoven, the Netherlands; 24 Institute of Community Medicine, University of Tromso, Tromso, Norway; 25 Department of Epidemiology, Catalan Institute of Oncology, Barcelona, Spain; 26 Andalusian School of Public Health, Granada, Spain; 27 Department of Public Health of Guipuzkoa, San Sebastian, Spain; 28 Public Health Institute, Navarra, Spain; 29 Epidemiology Department, Murcia Health Council, Murcia, Spain; 30 Dirección General de Salud Pública, Consejería de Salud y Servicios Sanitarios Asturias, Oviedo, Spain; 31 Malmö Diet and Cancer Study, Lund University, Malmö, Sweden; 32 Department of Nutritional Research, University of Umeå, Umeå, Sweden; 33 Cancer Research UK Epidemiology Unit, University of Oxford, Oxford, United Kingdom; and 34 Imperial College London, London, United Kingdom
Requests for reprints: Marco Peluso, Cancer Risk Factor Branch, CSPO-Scientific Institute of Tuscany Region, Villa Delle Rose, Via Cosimo il Vecchio N. 2, Florence, Italy 50139. Phone: 39-55-32-697867; Fax: 39-55-32-6978; E-mail: m.peluso{at}cspo.it.
Objectives were to investigate prospectively the ability of DNA adducts to predict cancer and to study the determinants of adducts, especially air pollutants. DNA adducts were measured in a case-control study nested in the European Prospective Investigation into Cancer and Nutrition (EPIC) investigation. Cases included newly diagnosed lung cancer (n = 115), upper respiratory cancers (pharynx and larynx; n = 82), bladder cancer (n = 124), leukemia (n = 166), and chronic obstructive pulmonary disease or emphysema deaths (n = 77) accrued after a median follow-up of 7 years among the EPIC former smokers and never-smokers. Three controls per case were matched for questionnaire analyses and two controls per case for laboratory analyses. Matching criteria were gender, age, smoking status, country of recruitment, and follow-up time. Individual exposure to air pollution was assessed using concentration data from monitoring stations in routine air quality monitoring networks. Leukocyte DNA adducts were analyzed blindly using 32P postlabeling technique. Adducts were associated with the subsequent risk of lung cancer, with an odds ratio (OR) of 1.86 [95% confidence interval (95% CI), 0.88-3.93] when comparing detectable versus nondetectable adducts. The association with lung cancer was stronger in never-smokers (OR, 4.04; 95% CI, 1.06-15.42) and among the younger age groups. After exclusion of the cancers occurring in the first 36 months of follow-up, the OR was 4.16 (95% CI, 1.24-13.88). A positive association was found between DNA adducts and ozone (O3) concentration. Our prospective study suggests that leukocyte DNA adducts may predict lung cancer risk of never-smokers. Besides, the association of DNA adduct levels with O3 indicates a possible role for photochemical smog in determining DNA damage.
This article has been cited by other articles:
![]() |
C. P. Wild Environmental exposure measurement in cancer epidemiology Mutagenesis, March 1, 2009; 24(2): 117 - 125. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Veglia, S. Loft, G. Matullo, M. Peluso, A. Munnia, F. Perera, D. H. Phillips, D. Tang, H. Autrup, O. Raaschou-Nielsen, et al. DNA adducts and cancer risk in prospective studies: a pooled analysis and a meta-analysis Carcinogenesis, May 1, 2008; 29(5): 932 - 936. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Vineis and F. Perera Molecular Epidemiology and Biomarkers in Etiologic Cancer Research: The New in Light of the Old Am. Assoc. Cancer Res. Educ. Book, April 12, 2008; 2008(1): 547 - 567. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. A. Rybicki, C. Neslund-Dudas, C. H. Bock, A. Rundle, A. T. Savera, J. J. Yang, N. L. Nock, and D. Tang Polycyclic Aromatic Hydrocarbon-DNA Adducts in Prostate and Biochemical Recurrence after Prostatectomy Clin. Cancer Res., February 1, 2008; 14(3): 750 - 757. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Munnia, F. Saletta, A. Allione, S. Piro, M. Confortini, G. Matullo, and M. Peluso 32P-Post-labelling method improvements for aromatic compound-related molecular epidemiology studies Mutagenesis, November 1, 2007; 22(6): 381 - 385. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Vineis and F. Perera Molecular Epidemiology and Biomarkers in Etiologic Cancer Research: The New in Light of the Old Cancer Epidemiol. Biomarkers Prev., October 1, 2007; 16(10): 1954 - 1965. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Castano-Vinyals, G. Talaska, N. Rothman, J. Alguacil, M. Garcia-Closas, M. Dosemeci, K. P. Cantor, N. Malats, F. X. Real, D. Silverman, et al. Bulky DNA Adduct Formation and Risk of Bladder Cancer Cancer Epidemiol. Biomarkers Prev., October 1, 2007; 16(10): 2155 - 2159. [Abstract] [Full Text] [PDF] |
||||
![]() |
P Vineis, F Veglia, S Garte, C Malaveille, G Matullo, A Dunning, M Peluso, L Airoldi, K Overvad, O Raaschou-Nielsen, et al. Genetic susceptibility according to three metabolic pathways in cancers of the lung and bladder and in myeloid leukemias in nonsmokers Ann. Onc., July 1, 2007; 18(7): 1230 - 1242. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Tuntawiroon, C. Mahidol, P. Navasumrit, H. Autrup, and M. Ruchirawat Increased health risk in Bangkok children exposed to polycyclic aromatic hydrocarbons from traffic-related sources Carcinogenesis, April 1, 2007; 28(4): 816 - 822. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Manuguerra, G. Matullo, F. Veglia, H. Autrup, A.M. Dunning, S. Garte, E. Gormally, C. Malaveille, S. Guarrera, S. Polidoro, et al. Multi-factor dimensionality reduction applied to a large prospective investigation on gene-gene and gene-environment interactions Carcinogenesis, February 1, 2007; 28(2): 414 - 422. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. M. Arlt, E. Frei, and H. H. Schmeiser ECNIS-sponsored workshop on biomarkers of exposure and cancer risk: DNA damage and DNA adduct detection and 6th GUM-32P-postlabelling workshop, German Cancer Research Center, Heidelberg, Germany, 29-30 September 2006 Mutagenesis, January 1, 2007; 22(1): 83 - 88. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Huang, M. R. Spitz, J. Gu, J.J. Lee, J. Lin, S. M.Lippman, and X. Wu Cyclin D1 gene polymorphism as a risk factor for oral premalignant lesions Carcinogenesis, October 1, 2006; 27(10): 2034 - 2037. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Gormally, P. Vineis, G. Matullo, F. Veglia, E. Caboux, E. Le Roux, M. Peluso, S. Garte, S. Guarrera, A. Munnia, et al. TP53 and KRAS2 Mutations in Plasma DNA of Healthy Subjects and Subsequent Cancer Occurrence: A Prospective Study. Cancer Res., July 1, 2006; 66(13): 6871 - 6876. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. B. Ketelslegers, R. W.H. Gottschalk, R. W.L. Godschalk, A. M. Knaapen, F. J. van Schooten, R. F.M.H. Vlietinck, J. C.S. Kleinjans, and J. H.M. van Delft Interindividual variations in DNA adduct levels assessed by analysis of multiple genetic polymorphisms in smokers. Cancer Epidemiol. Biomarkers Prev., April 1, 2006; 15(4): 624 - 629. [Abstract] [Full Text] [PDF] |
||||
![]() |
D M DeMarini and L D Claxton Outdoor air pollution and DNA damage. Occup. Environ. Med., April 1, 2006; 63(4): 227 - 229. [Full Text] [PDF] |
||||
![]() |
P. Vineis and K. Husgafvel-Pursiainen Air pollution and cancer: biomarker studies in human populations Carcinogenesis, November 1, 2005; 26(11): 1846 - 1855. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |